Open an account

RADNOSTIX

INIS · OTC

$0.047+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.047

Latest news

  • Press releasePRNewswire

    Radnostix and NANO Nuclear Energy Announce Joint Submission of Letter of Intent to NRC Seeking Consent for Transfer of License SUB-1011, Following Lea County Approval of Property LOI

  • Press releasePRNewswire

    Radnostix Signs Definitive Agreement to Divest DUF6 and Fluorine Assets to NANO Nuclear

  • Press releasePRNewswire

    Radnostix, Inc. Reports FY2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset Acquisition

  • Press releasePRNewswire

    Radnostix Acquires Lucerno Dynamics Assets Expanding Radiopharma Medical Device Portfolio

  • Press releasePRNewswire

    Radnostix, Inc. Reports FY2026 Q1 Results - Revenue Declines 27% Primarily Due to Voluntary Product Recalls, Isotope Supply Disruptions, and Planned Operational Shutdown

  • Press releasePRNewswire

    Radnostix, Inc. Reports FY2025 Results - Second-Highest Annual Revenue in Company History; Delivers Strong Growth in Calibration & Reference Products and Advances Key Product Launches in 2025

  • Press releasePRNewswire

    Mutual Termination of the Asset Purchase Agreement related to the Radnostix DUF6 Assets

  • Press releasePRNewswire

    International Isotopes Inc. Announces Company Name Change to Radnostix, Inc.

  • Press releasePRNewswire

    INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE THIRD QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2025

  • Press releasePRNewswire

    INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE SECOND QUARTER AND SIX MONTHS ENDED JUNE 30, 2025

  • Press releasePRNewswire

    INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE FIRST QUARTER 2025

  • Press releasePRNewswire

    INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR 2024

  • Press releasePRNewswire

    International Isotopes, Inc. Expands Operational Footprint with Strategic Land Acquisition and Additional New Facility Lease Agreement

  • Press releasePRNewswire

    International Isotopes, Inc. Announces the Amendment of the Acquisition of the AMICI, Inc. Product Line

  • Press releasePRNewswire

    INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE THIRD QUARTER AND FIRST NINE MONTHS OF 2024

  • Press releasePRNewswire

    International Isotopes Inc. and Phantech Medical Launch PhanQual to Revolutionize Calibration Sources for Pre-Clinical Imaging

  • Press releasePRNewswire

    INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE SECOND QUARTER AND FIRST SIX MONTHS OF 2024

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.